Rare diseases
Investigational molecules
Locations
Back to Germany82 clinical trials in Moenchengladbach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, evaluating innovative therapies including ribociclib and elacestrant combined with endocrine therapy.
Studies aim to improve survival rates and treatment effectiveness for various breast cancer subtypes.
Comprehensive research into chronic lymphocytic leukemia and lymphomas, investigating combinations of targeted therapies including venetoclax, ibrutinib, and obinutuzumab.
Focus on developing more effective treatment combinations for various blood cancers.
Innovative trials examining treatments for atherosclerotic cardiovascular disease and stroke prevention in patients with atrial fibrillation.
Research aims to improve cardiovascular outcomes and reduce major adverse cardiac events.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
